Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

HCA Healthcare remains a soft buy with improving fundamentals and strong buyback plans despite recent stock weakness.

Analyst Insights
07 Jul 2026
Seeking Alpha
View Source
Bullish
pluang ai news

HCA Healthcare is still considered a soft buy despite recent stock underperformance, as its revenue and profitability continue to grow driven by Medicare/Medicaid and higher admissions revenue. The company is shrinking its physical footprint but maintains strong shareholder returns through dividends and aggressive share buybacks, having reduced shares by 6.9% and retaining $9.18 billion in buyback capacity. Guidance for fiscal year 2026 projects revenue between $76.5 billion and $80 billion and EBITDA of $15.55 billion to $16.45 billion, supporting a positive long-term outlook for investors.

More News (HCA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App